New study uncovers key culprit behind pediatric brain cancer metastasis

byUniversity of Pittsburgha, A heatmap of gene expression in the four MB subgroups (G3, group 4 (G4), SHH and WNT) and in unaffected (normal) tissues. Twofold change; false discovery rate (FDR) 

Updated on: January 12,2024 10

New study uncovers key culprit behind pediatric brain cancer metastasis

byUniversity of Pittsburgha, A heatmap of gene expression in the four MB subgroups (G3, group 4 (G4), SHH and WNT) and in unaffected (normal) tissues. Twofold change; false discovery rate (FDR) 

Updated on:January 12,2024 10

Attenuation of cancer proliferation by suppression of glypican-1

by Impact Journals LLCOverexpression of GPC1 increases proliferation of T24 cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28388A new research paper titled "Attenuation of c

Updated on: February 01,2024 15

Attenuation of cancer proliferation by suppression of glypican-1

by Impact Journals LLCOverexpression of GPC1 increases proliferation of T24 cells. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28388A new research paper titled "Attenuation of c

Updated on:February 01,2024 15

Numbers count in the genetics of moles and melanomas

by University of QueenslandReticular naevi pattern (left) Gene variations: MTAP, PLA2G6, MITF. Globular naevi pattern (right) Gene variations: IRF4. Credit: University of QueenslandUniversity of

Updated on: April 20,2024 12

Numbers count in the genetics of moles and melanomas

by University of QueenslandReticular naevi pattern (left) Gene variations: MTAP, PLA2G6, MITF. Globular naevi pattern (right) Gene variations: IRF4. Credit: University of QueenslandUniversity of

Updated on:April 20,2024 12

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on: June 04,2024 6

Researchers set new bases to develop therapies against colorectal cancer

by IDIBELL-Bellvitge Biomedical Research InstituteDr. David G. Molleví and Dr. Natalia Guillén Díaz-Maroto, the group leader and first author of the study, respectively. Credit: Gemma FornonsRese

Updated on:June 04,2024 6

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024 15

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024 15

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on: June 22,2024 6

Researchers discover common markers of tumor hypoxia across 19 cancer types

by Ontario Institute for Cancer ResearchUnlike healthy tissues, tumours thrive in low-oxygen environments, often acquiring the ability to resist treatment and spread to other sites in the body. Despit

Updated on:June 22,2024 6

Investigational drug may combat brain tumors by targeting cancer cells' fat production

by Katie Marquedant,Massachusetts General HospitalCorrelation analysis between SCD expression and sensitivity to YTX-7739. (A) Immunoblot analysis (left) of SCD expression in YTX-7739-sensitive

Updated on: February 01,2024 18

Investigational drug may combat brain tumors by targeting cancer cells' fat production

by Katie Marquedant,Massachusetts General HospitalCorrelation analysis between SCD expression and sensitivity to YTX-7739. (A) Immunoblot analysis (left) of SCD expression in YTX-7739-sensitive

Updated on:February 01,2024 18

Researchers develop an improved hereditary cancer test

by University of British ColumbiaCredit:Cell Genomics(2022). DOI: 10.1016/j.xgen.2022.100233Researchers at the BC Cancer Research Institute have made an advancement in genetic testing

Updated on: February 03,2024 15

Researchers develop an improved hereditary cancer test

by University of British ColumbiaCredit:Cell Genomics(2022). DOI: 10.1016/j.xgen.2022.100233Researchers at the BC Cancer Research Institute have made an advancement in genetic testing

Updated on:February 03,2024 15

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on: August 30,2025 0

AI-Assisted Histopathology: Refining the Distinction Between Sebaceous and Squamous Cell Carcinoma of the Eyelid

Updated on:August 30,2025 0

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024 13

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024 13

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on: January 22,2024 16

Tumor matrix profiling gives clues to progression of some lung cancers

byGarvan Institute of Medical ResearchGraphic of lungs and cells. Credit: Thomas Cox/Garvan InstituteScientists at the Garvan Institute of Medical Research have identified molecular profiles of

Updated on:January 22,2024 16

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on: March 20,2024 15

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on:March 20,2024 15